Intranasal antigen targeting to MHC class II molecules primes local IgA and serum IgG antibody responses in mice

Immunology

Volumn 90, Issue 3, 1997, Pages 323-329

  Snider, D P ^a   Underdown, B J ^a   Mcdermott, M R ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; LYSOZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; INTRANASAL DRUG ADMINISTRATION; LUNG LAVAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; UPPER RESPIRATORY TRACT;

EID: 0031051720     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.1997.00323.x     Document Type: Article

References (34)

1. FRASCH C.E. (1989) Vaccines for prevention of meningococcal disease. Clin Microbiol Rev 2, 5134.
2. FINE P.E.M. & RODRIGUES L.C. (1991) Modern vaccines: mycobacterial diseases. Lancet 335, 1016.
3. TREANOR J.J., MATTISON H.R., DUMYATI G., YINNON A., ERB S. & O'BRIEN D. (1992) Protective efficacy of combined live intranasal and inactivated influenza A vaccines in the elderly. Ann Intern Med 117, 625.
4. KILIAN M. & RUSSELL M.W. (1994) Function of mucosal immunoglobulins. In: Handbook of Mucosal Immunology (eds P. L. Ogra, J. Mestecky, M. E. Lamm, W. Strober, J. R. McGhee & J. Bienenstock), p. 127. Academic Press, San Diego.
5. MCDERMOTT M.R., BEFUS A.D. & BIENENSTOCK J. (1982) The structural basis for immunity in the respiratory tract, Int Rev Exp Pathol 23, 47.
6. TAMURA S., KURATA H., FUNATO H., NAGAMINE T., AIZAWA C. & KURATA T. (1989) Protection against influenza virus infection by a two-dose regimen of nasal vaccination using vaccines combined with cholera toxin B subunit. Vaccine 7, 314.
7. NEDRUD J.G., LIANG X., HAGUE N. & LAMM M.E. (1987) Combined oral/nasal immunization protects mice from Sendai virus infection. J Immunol 139, 3484.
8. Wu H.Y. & RUSSELL M.W. (1993) Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect Immun 61, 314.
9. HAMELEERS D.M.H., VAN DER VEN I., BIEWENGA J. & SMINIA T. (1991) Mucosal and systemic antibody formation in the rat after intranasal administration of three different antigens. Immunol Cell Biol 69, 119.
10. ARAMAKI Y., FUJII Y., YACHI K., KIKUCHI H. & TSUCHIYA S. (1994) Activation of systemic and mucosal immune response following nasal administration of liposomes, Vaccine 12, 1241.
11. LANGERMANN S., PALASZYNSKI S., SADZIENE A., STOVER C.K. & KOENIG S. (1994) Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi. Nature 372, 552.
12. CAHILL E.S., O'HAGAN D.T., ILLUM L., BARNARD A., MILLS K.H.G. & REDHEAD K. (1995) Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles. Vaccine 13, 455.
13. REUMAN P.D., KEELY S.P. & SCHIFF G.M. (1991) Similar subclass antibody responses after intranasal immunization with UV-inactivated RSV mixed with cholera toxin or live RSV. J Med Virol 35, 192.
14. TAMURA S., YAMANAKA A., SHIMOHARA M. et al. (1994) Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine 12, 419.
15. DE HAAN A., GEERLIGS H.J., HUCHSHORN J.P., VAN SCHARRENBURG G.J.M., PALACHE A.M. & WILSCHUT J. (1995) Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and co-administered liposomes. Vaccine 13, 155.
16. LOEVGREN K., KABERG H. & MOREIN B. (1990) An experimental influenza subunit vaccine (iscom): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration. Clin Exp Immunol 82, 435.
17. TAMURA S.-I., ITO Y., ASANUMA H. et al. (1992) Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. J Immunol 149, 981.
18. SNIDER D.P., KAUBISCH A. & SEGAL D.M. (1990) Enhanced antigen immunogenicity induced by bispecific antibodies. J Exp Med 171, 1957.
19. CARAYANNIOTIS G. & BARBER B.H. (1987) Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC. Nature 327, 59.
20. MJAALAND S. & FOSSUM S. (1990) Modulation of immune responses with monoclonal antibodies. I. Effects on regional lymph node morphology and on anti-hapten responses to haptenized monoclonal antibodies. Eur J Immunol 20, 1457.
21. ESTRADA A., MCDERMOTT M.R., UNDERDOWN B.J. & SNIDER D.P. (1995) Intestinal immunization of mice with antigen conjugated to anti-MHC class II antibodies. Vaccine 13, 901.
22. SNIDER D.P. (1994) Adjuvant-free polyclonal antibody response manipulated by antibody-mediated antigen targeting. In: Antibody Techniques A Guide for Non-Immunologists (eds E. P. Lillehoj & V. S. Malik), p. 49. Academic Press, New York.
23. HEUKESHOVEN J. & DERNICK R. (1988) Improved silver stain procedure for fast staining in Phastsystem development units. I. Staining of sodium dodecyl sulfate gels. Electrophoresis 9, 28.
24. SNIDER D.P., MARSHALL J.S., PERDUE M.H. & LIANG H. (1994) Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues following oral immunization with protein antigen and cholera toxin. J Immunol 153, 647.
25. ELSON C.O. & EALDING W. (1984) Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J Immunol 132, 2736.
26. SNAPPER C.M. & MOND J.J. (1993) Towards a comprehensive view of immunoglobulin class switching. Immunol Today 14, 15.
27. XU-AMANO J., AICHER W.K., TAGUCHI T., KIYONO H. & MCGHEE J.R. (1992) Selective induction of Th2 cells in murine Peyer's patches by oral immunization. Int Immunol 4, 433.
28. + T cells of Th1 and Th2 type in salivary gland-associated tissues. Eur J Immunol 24, 2653.
29. GRAHAM M.B., DALTON D.K., GILTINAN D., BRACIALE V.L., STEWARD T.A. & BRACIALE T.J. (1993) Response to influenza infection in mice with a targeted distruption in the Interferon ; gene. J Exp Med 178, 1725.
30. FAZEKAS G., ROSENWIRTH B., DUKOR P., GERGELY J. & RAJNAVÖLGYI É. (1994) IgG isotype distribution of local and systemic immune responses induced by influenza virus infection. Eur J Immunol 24, 3063.
31. IWASAKI T. & NOZIMA T. (1977) Defense mechanisms against primary influenza virus infection in mice. I. The roles of interferon and neutralizing antibodies and thymus dependence of interferon and antibody production. J Immunol 118, 256.
32. SPIT B.J., HENDRIKSEN E.G.J., BRUIJNTJES J.P. & KUPER C.F. (1989) Nasal lymphoid tissue in the rat. Cell Tissue Res 255, 193.
33. OWEN R.L. (1994) M cells - entryways of opportunity for enteropathogens. J Exp Med 180, 7.
34. WELTZIN R., LUCIA-JANDRIS P., MICHETTI P., FIELDS B.N., KRAEHENBUHL J.P. & NEUTRA M.R. (1989) Binding and transepithelial transport of immunoglobulins by intestinal M cells: demonstration using monoclonal IgA antibodies against enteric viral proteins. J Cell Biol 108, 1673.